Support the Cancer Drug Parity Act
We apologize, but the action alert you are attempting to access is no longer active.
Consider taking action on other issues.
Support H.R. 4385 | |
This legislation would protect the approximately 140 million patients covered by federally regulated group health plans by ending the preference for cancer care that is not administered orally. |